Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.00 (0.00%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.03m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Placing

14 Oct 2009 07:00

RNS Number : 7162A
Sabien Technology Group PLC
14 October 2009
 



14 October 2009

Sabien Technology Group plc

("Sabien" or "the Company")

GBP1.475 million Placing

Placing of 4,916,000 Ordinary Shares at 30 pence per share to raise  approximately  GBP1.475 million from institutional and other investors

Placing to support the Company's growth and working capital requirements

Funds raised will also allow the Company to repay the TVI 2 Limited ("TVI 2") loan early thereby reducing the number of warrants issued to TVI 2 from 2,952,279 to 1,518,356 and leaving the Company debt free

Sabien, the manufacturer and supplier of M2G, an energy efficiency technology, is pleased to announce that it has conditionally placed 4,916,000 new ordinary shares of 5 pence each (the "Placing Shares") at a price of 30 pence per share (the "Placing Price"), raising approximately GBP1.475 million (before  expenses) for the Company from a number of institutional and other investors (the "Placing") through Arbuthnot Securities.

The funds raised from the Placing will provide Sabien with the capital necessary to support the  Company's working capital requirements and will allow it to continue to grow its prospective pipeline  for the installation of M2G devices, which currently stands at c. 3,000 devices

The Placing Shares have been conditionally placed with institutional and other investors by Arbuthnot Securities Limited. The Placing Shares will, when issued, rank pari passu with the Company's existing issued ordinary shares, and dealings are expected to commence in the Placing Shares on Monday19 October 2009 ("Admission"). 

 

Alan O'Brien, Chief Executive Officer for Sabien said:

"I am very pleased by the support we have received from existing and new shareholders. The funds raised through this placing provide Sabien with the resources to pursue its growth strategy in the European and US markets and to repay its loan to TVI 2 leaving the company completely debt free. Early repayment of the TVI 2 loan means that approximately 50 per cent. of the warrants issued to TVI 2 will be cancelled. I would also like to thank all our advisers for a job well done." 

Total Voting Rights

Following Admission, the total number of issued ordinary shares of 5 pence each in the Company (the "Ordinary Shares") will be 31,486,511. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules. 

For further information:

 Sabien Technology Group plc 

 Alan O'Brien, CEO

Tel: +44 (0) 20 7993 3700

 Gus Orchard, CFO

www.sabien-tech.co.uk

Arbuthnot Securities Limited

 Antonio Bossi

Tel: +44 (0) 20 7012 2000

www.arbuthnotsecurities.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEILFIRITLVLIA
Date   Source Headline
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract
1st Jun 20107:00 amRNSTrading Statement
17th May 20107:00 amRNSChange of Adviser
1st Apr 201012:37 pmRNSGrant of options
25th Feb 20107:00 amRNSHalf Yearly Report
2nd Dec 20097:00 amRNSNew Contract Win
9th Nov 20097:00 amRNSAdjustment to number of warrants in issue
28th Oct 20097:00 amRNSPreliminary Results - 12 months ended 30 June 2009
14th Oct 20097:00 amRNSPlacing
7th Oct 20097:00 amRNSContract award
28th Sep 200911:40 amRNSAlliance Agreement with Jones Lang LaSalle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.